1:Walt
1:Walt
Also known as: 1-Walt, 1 Walt
Overview
1:Walt is a specialized medicinal cannabis strain developed by Mephisto Genetics, representing a meshing of two of their longest projects. Created by crossing Walter White BX1 with an all-CBD phenotype isolated from their Canna-Cheese 1:1 strain, this F1 hybrid was designed to produce a balanced 1:1 CBD:THC ratio. During their reworking of the current generation of Canna-Cheese 1:1, Mephisto Genetics isolated specimens of an all-CBD phenotype testing at around 24:1 CBD:THC, which they paired with selections of their new high THC catalogue favourites. The strain is expected to produce a roughly 1:1 CBD:THC ratio from this F1 cross, resulting in a slightly sativa-leaning hybrid with good vigour and a creeping high that raises mood and productivity. As an autoflowering strain combining ruderalis, indica, and sativa genetics, 1:Walt can be cultivated both indoors and outdoors and is only available as feminized seeds. This strain represents Mephisto Genetics' commitment to developing balanced cannabinoid profiles for medical users seeking the therapeutic benefits of both THC and CBD without overwhelming psychoactive effects.
Effects
Reported Medical Uses
- Users report mood enhancement
- May help with stress relief
- Often used for pain management
- Potentially beneficial for anxiety
- May aid focus and concentration
This is not medical advice. Consult a healthcare professional.
Possible Negative Effects
Growing Information
1:Walt is a ruderalis/indica/sativa hybrid that can be cultivated both indoors and outdoors. The strain is only available as feminized seeds. This autoflowering strain completes its life cycle from seed to harvest in approximately 70-80 days and is suitable for both novice and experienced cultivators. It flourishes in various growing environments and when grown under optimal conditions, reports suggest yields of up to 136 grams per plant. The strain exhibits good vigour and adaptability, making it accessible for growers of different skill levels. Due to its balanced CBD:THC genetics, it may be particularly appealing to medical growers seeking therapeutic cannabinoid profiles.